These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28823185)

  • 21. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK; Tabberer M; Brooks J
    Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?
    Kharroubi SA; Rowen D
    Eur J Health Econ; 2019 Mar; 20(2):245-255. PubMed ID: 29980950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders.
    Grochtdreis T; Brettschneider C; Hajek A; Schierz K; Hoyer J; Koenig HH
    J Ment Health Policy Econ; 2016 Jun; 19(2):79-89. PubMed ID: 27453455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.
    Kharroubi SA
    Health Qual Life Outcomes; 2017 Oct; 15(1):195. PubMed ID: 28985757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing quality of life in a clinical study on heart rehabilitation patients: how well do value sets based on given or experienced health states reflect patients' valuations?
    Leidl R; Schweikert B; Hahmann H; Steinacker JM; Reitmeir P
    Health Qual Life Outcomes; 2016 Mar; 14():48. PubMed ID: 27005466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN; Olsen JA
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
    Couzner L; Crotty M; Norman R; Ratcliffe J
    Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of health state selection on the valuation of EQ-5D.
    Chuang LH; Kind P
    Med Decis Making; 2011; 31(1):186-94. PubMed ID: 20671210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index?
    Simons CL; Rivero-Arias O; Yu LM; Simon J
    Qual Life Res; 2015 Apr; 24(4):805-15. PubMed ID: 25471286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.
    Franklin M; Payne K; Elliott RA
    Med Decis Making; 2018 Jan; 38(1):79-94. PubMed ID: 29056069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets.
    Lamers LM
    Med Care; 2007 Mar; 45(3):238-44. PubMed ID: 17304081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
    Doble B; Lorgelly P
    Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications.
    Hansen TM; Stavem K; Rand K
    MDM Policy Pract; 2022; 7(1):23814683221083839. PubMed ID: 35281553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
    Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
    J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
    Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
    Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient versus general population health state valuations: a case study of non-specific low back pain.
    van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
    Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.